RELISH PHARMA Fact Sheet, RELISH PHARMA Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

RELISH PHARMA Fact Sheet    (RELP)


EXPOSED: The Shocking Truth Behind Today's Hottest Investment Opportunity


Here is the latest financial fact sheet of RELISH PHARMA. For more details, see the RELISH PHARMA quarterly results and RELISH PHARMA share price and chart. For a sector overview, read our pharmaceuticals sector report.

RELISH PHARMA Price History

Price Rs 68.4
Mkt Cap Rs m 107
Vol '000 0.2
P/E X 324.5
P/CF X 6.4
EPS (TTM) Rs 0.2
1 Day % -5.0
No. of shares m 1.57
1 Week % -2.4
1 Month % -16.5
1 Year % 77.2
52 week H/L Rs 108.1/36.7
As on Jan 25, 2022 (Close)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

RELISH PHARMA Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
RELISH PHARMA EQUITY SHARE DATA
High Rs97831666157 
Low Rs4837262625 
Sales per share (Unadj.) Rs32.731.530.063.452.7 
Earnings per share (Unadj.) Rs3.23.42.90.21.2 
Diluted earnings per shareRs3.23.43.00.21.2 
Cash flow per share (Unadj.) Rs6.28.09.19.610.6 
Dividends per share (Unadj.) Rs0.500.500.5000 
Adj. dividends per shareRs0.500.500.500.000.00 
Avg Dividend yield %0.70.80.500 
Book value per share (Unadj.) Rs92.895.697.998.299.4 
Adj. book value per shareRs93.195.998.298.499.6 
Shares outstanding (eoy) m1.571.571.571.571.57 
Bonus / Rights / Conversions  ----- 
Price / Sales ratio x2.21.93.20.70.8 
Avg P/E ratio x22.517.832.6191.433.9 
P/CF ratio (eoy) x11.77.410.64.53.8 
Price / Book Value ratio x0.80.61.00.40.4 
Dividend payout %15.614.916.900 
Avg Mkt Cap Rs m113941516864 
No. of employees `000NANANANANA 
Total wages/salary Rs m1012194337 
Avg. sales/employee Rs ThNMNMNMNMNM 
Avg. wages/employee Rs ThNMNMNMNMNM 
Avg. net profit/employee Rs ThNMNMNMNMNM 
RELISH PHARMA INCOME DATA
Net Sales Rs m51494710083 
Other income Rs m11004 
Total revenues Rs m52514710086 
Gross profit Rs m1516161612 
Depreciation Rs m57101515 
Interest Rs m00000 
Profit before tax Rs m119721 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m6431-1 
Profit after tax Rs m55502 
Gross profit margin %28.632.635.016.515.1 
Effective tax rate %52.544.436.279.1-92.2 
Net profit margin %9.810.69.80.42.3 
RELISH PHARMA BALANCE SHEET DATA
Current assets Rs m7183111145153 
Current liabilities Rs m1727407062 
Net working cap to sales %104.5113.6150.275.0109.0 
Current ratio x4.13.12.82.12.4 
Inventory Days Days33429 
Debtors Days Days176216414291392,409,587 
Net fixed assets Rs m119158173191195 
Share capital Rs m1616161616 
"Free" reserves Rs m130134138138140 
Net worth Rs m146150154154156 
Long term debt Rs m036618198 
Total assets Rs m189241284335348 
Interest coverage x177.324.7725.086.54.0 
Debt to equity ratio x00.20.40.50.6 
Sales to assets ratio x0.30.20.20.30.2 
Return on assets %2.72.31.60.10.6 
Return on equity %3.43.53.00.21.2 
Return on capital %7.35.33.40.70.5 
Exports to sales %00000 
Imports to sales %00000 
Exports (fob) Rs m00000 
Imports (cif) Rs m00000 
Fx inflow Rs m10000 
Fx outflow Rs m120030 
Net fx Rs m0-200-30 
RELISH PHARMA CASH FLOW
From Operations Rs m -3 8 3 12 4 
From Investments Rs m -9 -48 -25 -31 -18 
From Financial Activity Rs m 0 35 24 18 17 
Net Cashflow Rs m -12 -5 2 -1 3 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 49.2%
Institution 0.8%
Non-Institution 50.0%
Total 100.0%
Free Float 50.8%
Pledged promoter holdings 0.0%
Shareholding as on Dec 2021
 

Company Information

Regd Off 3rd Floor Dev House, Opp Wiaa Office, Judges Bungalows Road Bodakdev, Ahmedabad - 380054
E-mail info@shukrapharmaceuticals.com Web www.shukrapharmaceuticals.com
Tel 079-27498515 Fax
Sector PHARMACEUTICALS Group Private sector
Tr Agent Purva Shareregistry (India) Pvt Ltd, Gala No 9, Shiv Shakti Industrial Estate Sitaram Mill Comp., J R Boricha Marg Lower Parel [E]
YEAR OF INC: 1993 BSE CODE: 524632 FV (Rs): 10 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    

Compare RELISH PHARMA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    




Today's Market

TVS Acquires Largest Swiss E-Bike Company, Canara Bank Quarterly Results, and Buzzing Stocks Today(Pre-Open)

Indian share markets ended on a weak note yesterday.

Views on news

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look? (Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive? (Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist (Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here... (Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022 (Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK RELISH PHARMA

  • Track your investment in RELISH PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON RELISH PHARMA

RELISH PHARMA - ACTAVIS COMPARISON

COMPARE RELISH PHARMA WITH

MARKET STATS